Latest Health News

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

Tribune Resources Limited has announced an on-market buy-back of up to 5.25 million shares, signaling confidence in its capital structure and aiming to enhance shareholder value over the next year.

Freehill Mining Ltd’s December quarter cash flow report reveals a $114,000 net cash outflow from operations but highlights a solid liquidity position with $301,000 in unused financing facilities.

Kinetiko Energy reports mixed results from its five-well gas production test program, with the first well underperforming but the company maintaining optimism for the remaining wells and a strong financial footing.

Emperor Energy Limited reported a net operating cash outflow of $376,000 for the December quarter but bolstered its cash reserves with a $3.6 million financing inflow, ending the period with $3.4 million in cash.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Norfolk Metals reports progress in its Orroroo Uranium and Roger River projects, unveiling new exploration targets and maintaining a solid financial footing with $2.66 million in cash.

AGUIA RESOURCES LTD posted a $1.31 million net cash outflow for the December 2024 quarter, driven by exploration and evaluation expenses, while preparing for underground operations at its Santa Barbara Mine.

Reedy Lagoon Corporation reports promising soil sampling results at its Burracoppin Gold project while seeking partners for its iron venture amid challenging market conditions.

Po Valley Energy Limited reports a robust December 2024 quarter marked by rising gas production, strong revenue growth, and significant progress in exploration and development across its Italian assets.

HeraMED reports a surge in its HeraCARE platform users and secures $4.1 million in new funding, underpinning its expansion in the US maternity care market and integration with major health systems.

dorsaVi reported a modest 1.9% rise in sales revenue to $330k in Q2 FY25, launched its AI-powered Video AI movement analysis platform, and initiated a blockchain integration partnership to enhance data security.